Greenlight Capital - Performance Analysis
Investment performance metrics based on historical 13F filings data.
📊 Data Coverage: March 2026 to March 2026 • Initial Portfolio Value: $2.91B
Performance calculated from first filing in our database. This may not represent the investor's entire career.
Portfolio Growth (Since First Filing)
+0.00B
+0.00%
Winning Positions
0.00%
0 wins / 40 positions
Average Gain (Winners)
$0.00
0.00% avg per position
Active Positions
40
0 losing positions
Portfolio Value Over Time
Total Positions Tracked
40
All holdings over time
Win/Loss Ratio
0.00
0 gains / 0 losses
Active vs. Exited
40 / 0
Current positions / Exited
Position Performance
Performance calculated from first appearance in 13F filings. Initial values represent position value when first tracked, not actual purchase prices.
| Symbol | Company | Sector | Entry | Status | Initial Value | Current Value | Gain/Loss | Return % |
|---|---|---|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company, Inc. | Healthcare | Mar 2026 | ACTIVE | $105.68M | $105.68M | $0.00 | 0.00% |
| AR | Antero Resources Corporation | Energy | Mar 2026 | ACTIVE | $34.31M | $34.31M | $0.00 | 0.00% |
| AXL | American Axle & Manufacturing H | Consumer Cyclical | Mar 2026 | ACTIVE | $37.43M | $37.43M | $0.00 | 0.00% |
| BHF | Brighthouse Financial, Inc. | Financial Services | Mar 2026 | ACTIVE | $170.18M | $170.18M | $0.00 | 0.00% |
| CEIX | Core Natural Resources | N/A | Mar 2026 | ACTIVE | $194.60M | $194.60M | $0.00 | 0.00% |
| CI | The Cigna Group | Healthcare | Mar 2026 | ACTIVE | $23.58M | $23.58M | $0.00 | 0.00% |
| CNC | Centene Corporation | Healthcare | Mar 2026 | ACTIVE | $89.44M | $89.44M | $0.00 | 0.00% |
| CNH | CNH Industrial | N/A | Mar 2026 | ACTIVE | $46.08M | $46.08M | $0.00 | 0.00% |
| COYA | Coya Therapeutics, Inc. | Healthcare | Mar 2026 | ACTIVE | $9.20M | $9.20M | $0.00 | 0.00% |
| CPRI | Capri Holdings | N/A | Mar 2026 | ACTIVE | $86.87M | $86.87M | $0.00 | 0.00% |
Important Note: Data Limitations
These metrics are based on 13F filing data which has significant limitations:
- Quarterly Snapshots Only: 13F filings show positions at quarter-end, not actual transaction prices
- No Transaction Prices: We cannot determine actual buy/sell prices, only end-of-quarter values
- Performance Estimates: Gains/losses are calculated from first appearance to last update using quarterly values
- Missing Data: Intra-quarter trades, dividends, corporate actions, and exact timing are not captured
- Educational Only: These metrics are estimates for understanding general investment patterns, not actual realized returns
Use these metrics for informational and educational purposes only. They represent broad trends, not precise investment performance.